Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Statin treatment and muscle symptoms: a series of randomised, placebo controlled N-of-1 trials

ARMITAGE J., (2020), BMJ: British Medical Journal

Comparison of four methods to measure haemoglobin concentrations in whole blood donors ( COMPARE ): A diagnostic accuracy study

Bell S. et al, (2020), Transfusion Medicine

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342

Use of run-in periods in randomized trials

Huo X. and ARMITAGE J., (2020), JAMA: Journal of the American Medical Association

Effects of Omega-3 Fatty Acid Supplements on Arrhythmias.

Parish S. et al, (2020), Circulation, 141, 331 - 333

Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

HPS2-THRIVE Collaborative Group None. et al, (2019), Trials, 20

Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis.

Yao P. et al, (2019), JAMA Netw Open, 2

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study.

Mafham MM. et al, (2019), Diabetologia

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Hammami I. et al, (2019), EUROPEAN HEART JOURNAL, 40, 265 - 265

Serious Adverse Effects of Extended-Release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.

Haynes R. et al, (2019), Clin Ther

Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.

Kaptoge S. et al, (2019), Lancet Haematol

Longer-term safety and efficiency of varying the frequency of whole blood donation: extension of the INTERVAL trial in 20,757 blood donors

ARMITAGE JANE. and Roberts D., (2019), The Lancet Haematology

Comment on Kim et al. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes Care 2019;42:3-9.

Huo X. et al, (2019), Diabetes Care, 42

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.

Al-Shahi Salman R. et al, (2019), Lancet Neurol, 18, 643 - 652

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

RESTART Collaboration None., (2019), Lancet, 393, 2613 - 2623

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kitas GD. et al, (2019), Arthritis Rheumatol

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials.

Offer A. et al, (2019), JAMA Netw Open, 2

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.

Armitage J. et al, (2019), J Am Coll Cardiol, 73, 477 - 487

Inhibition of cholesteryl ester transfer protein for the prevention of cardiovascular events

PREISS D. et al, (2019), JACC - Journal of the American College of Cardiology

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?